Navigation Links
New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits
Date:3/14/2009

nflammation and swelling of the airways and constriction of the muscles of the bronchial passages. Currently, the recommended drug therapies for treating asthma include the long-term use of inhaled corticosteroids to reduce airway inflammation and mucus production.

Statins are medications used to lower cholesterol levels in the blood and to reduce the risk of heart attack and stroke, but also have known anti-inflammatory properties that may play a role in protecting patients against cardiovascular disease. These same anti-inflammatory effects have also been a subject of interest in the treatment of asthma although statins are currently not approved for use as an asthma medication. As many as 20 to 30 percent of adults with asthma are estimated to also have conditions, such as established cardiovascular disease or diabetes mellitus, for which statin therapy may be indicated.

About Medco

Medco Health Solutions, Inc (NYSE: MHS) is a leading health care company, serving the needs of more than 60 million people. Medco, the world's most advanced pharmacy(R), provides clinically driven pharmacy services designed to improve the quality of care and lower total health care costs for private and public employers, health plans, labor unions and government agencies of all sizes, and for individuals served by Medicare Part D Prescription Drug Plans. Through its unique Medco Therapeutic Resource Centers(R) and the Accredo Health Group, Medco's Specialty Pharmacy, the company is creating innovative models for the care of patients with chronic and complex conditions. Medco is a leader in the emerging field of personalized medicine and in applying evidence-based protocols to elevate the practice of pharmacy -a key element in reforming America's health care system. Medco is ranked number 51 on the Fort
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... -- AMRI (NASDAQ: AMRI ) announced today that ... of VP of International Sales, effective immediately. He reports ... Global Sales and Marketing. In this ... in an effort to increase worldwide customer value and ... will drive strategy for sales and marketing efforts across ...
(Date:3/5/2015)... , March 5, 2015 LUNGevity ... the Food and Drug Administration,s (FDA) approval of ... Opdivo and other immunotherapy treatments add another critical ... harnessing the power of a patient,s own immune ... has been approved specifically for patients with squamous ...
(Date:3/5/2015)... 2015 Research and Markets ( ... "Global Pharma US & EU Outlook 2015: ... Role In Shaping Up Business for Large Cap ... Strategy Diversification Divested: Productivity measurements, Divestment ... Will accelerate Next wave of targeted acquisition ...
Breaking Medicine Technology:AMRI Hires VP of International Sales 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3
... 3, 2011 Cornerstone Pharmaceuticals and Wake ... a Phase I clinical trial of Cornerstone,s first-in-class cancer ... Data will be presented at the 47th Annual meeting ... . Cornerstone is a leader in the discovery and ...
... FRANKLIN LAKES, N.J., June 3, 2011 BD (Becton, Dickinson and ... company, announced today that it will present at the Goldman Sachs ... 11:00 am (ET). A live webcast of BD,s ... www.bd.com/investors and will be available for replay through Thursday, June ...
Cached Medicine Technology:Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 2Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 3Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 4
(Date:3/6/2015)... Coral Springs, FL (PRWEB) March 06, 2015 ... to present March 2015 air dates for Spokane, Washington and ... life, colorful places to shop and dine, and many outdoor ... main industry supporting the local economy. Six major hospitals call ... Northwest to the Canadian border. The medically-focused cable TV program ...
(Date:3/6/2015)... Alexandria, Virginia (PRWEB) March 06, 2015 ... today it has awarded five-year accreditation status to seven ... Committee mean that another 1.3 million people can now ... to protect and promote the health of their communities. ... protecting and improving the health of people and communities. ...
(Date:3/5/2015)... 05, 2015 This week, ... in low-cost laminate flooring products, initiating widespread concern ... eco-friendly building materials made primarily from bamboo, stands ... all their flooring products for volatile organic compounds ... Benchmark International (BMH). Results from formaldehyde emissions ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased ... brand’s new logo and optimized website. , ... approach to expert diagnostic imaging, centered on patient care. ... to be a resource for Nebraska patients and a ... communication and referral functionality, video content and resources to ...
(Date:3/5/2015)... SuperCloset has released a new video series called ... teach viewers everything they need to know about how to ... takes you from seed all the way through harvest, and ... to prune Grow Like a SuperPro will help take the ... for download for a special introductory price of $19.95. Or ...
Breaking Medicine News(10 mins):Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Central Nebraska Imaging Center Gets Rebranding 2
... best available option for people with hemochromatosis , , ... dismissed as a primitive form of medicine, in which ... humors by draining the life-sustaining fluid. , But there,s ... the preferred means of treatment. , Hemochromatosis is an ...
... Paramore to Address VIP Guests in Connection with the ... ... Emdeon Business,Services, a leading provider of revenue cycle management and ... Forum to be held Monday, August 25th, at the Democratic,National Convention ...
... NEW ROCHELLE, N.Y., Aug. 25 Borrowing and ... public health concern. A,survey of nearly 7,500 women ... among more than one-third of this population, according ... Journal of Women,s Health, a,peer-reviewed journal published by ...
... list ... DOVER, N.H., Aug. 25 Planet Fitness, the ... friendly prices, earned,the top spot among all fitness companies ... businesses in the United States., (Logo: http://www.newscom.com/cgi-bin/prnh/20080825/NEM084LOGO ...
... 25, 2008 The U.S. Pharmacopeial (USP) Convention today ... patients, caregivers, pharmacists, physicians and others in avoiding medication ... look alike and/or sound alike. This "Drug Error Finder" ... drugs reported to be involved in medication mix-ups in ...
... recommend consulting with school staff on avoidance strategies , , ... school staff need to take measures to ensure the ... with food allergies, says the American Academy of Allergy, ... parents and school staff is a key ingredient to ...
Cached Medicine News:Health News:For Rare Blood Disorder, Pumping Iron Is the Cure 2Health News:For Rare Blood Disorder, Pumping Iron Is the Cure 3Health News:Nashville's Emdeon Business Services to Co-Sponsor Democratic National Convention Health Policy Event 2Health News:Trends in Prescription Medication Sharing Among Reproductive-Aged Women Reported in Journal of Women's Health 2Health News:N.H.-Based Health Club Operator Sets The Industry's Pace 2Health News:USP announces new tool to help prevent medication mix-ups due to look alike/sound alike drug names 2Health News:Food Allergy Action Plan Can Keep Kids From Harm 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: